Appelbaum Kevin J 4
4 · Better Therapeutics, Inc. · Filed Dec 17, 2021
Insider Transaction Report
Form 4
Appelbaum Kevin J
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-12-15$4.71/sh+750$3,530→ 2,750 total
Holdings
- 2,406,719(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of Issuer.